Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating multiple doses of tapentadol (CG5503) in patients awaiting joint replacement surgery has completed, assessing effectiveness and safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Tapentadol (Tapentadol hydrochloride)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Osteoarthritis, Pain Assessment | Phase 3 | Status: COMPLETED